Literature DB >> 3556196

Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.

J Schneider-Schaulies, A Schimpl, E Wecker.   

Abstract

Newly isolated lymphocytes from mouse spleens express the c-fos oncogene even in the absence of mitogen with maximal mRNA levels 60 min post preparation of single cell suspension, whereas c-myc mRNA levels increase only after mitogenic stimulation with maximal mRNA levels 6 h post stimulation. The half-lives of c-fos mRNA are generally very short; they increase from 14 min (after 30 min of culture) to 70 min (after 2 h of culture). The half-lives of c-myc mRNA decrease from 50 min (at 2 and 6 h post stimulation with concanavalin A) to 12 min (at 48 h post stimulation). The c-fos gene transcription is already turned on in time-0 lymphocytes 10 min after disruption of the organ structure of the spleens and is down-regulated after 2 h and later. In nuclear run-on experiments with nonstimulated lymphocytes there is already significant transcription of the first exon of c-myc, but almost no elongation of the transcript to exon 2 and 3. In concanavalin A-treated lymphocytes elongation is stimulated about 5-fold within 6 h and returns to background levels at 48 h post stimulation. The nuclear run-on analyses of nonactivated lymphocytes showed a signal for RNA complementary to c-myc mRNA detected with a probe specific for the exon 1/intron 1 boundary of c-myc, which disappeared with increasing time of concanavalin A stimulation. This anti-sense transcription may play a role in regulating the elongation of c-myc transcripts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556196     DOI: 10.1002/eji.1830170521

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Control of formation of two distinct classes of RNA polymerase II elongation complexes.

Authors:  N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 2.  Emerging themes in neuronal activity-dependent gene expression.

Authors:  Ram Madabhushi; Tae-Kyung Kim
Journal:  Mol Cell Neurosci       Date:  2017-12-15       Impact factor: 4.314

3.  A heat-labile factor promotes premature 3' end formation in exon 1 of the murine adenosine deaminase gene in a cell-free transcription system.

Authors:  J W Innis; R E Kellems
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  c-fos gene transcription in murine macrophages is modulated by a calcium-dependent block to elongation in intron 1.

Authors:  M A Collart; N Tourkine; D Belin; P Vassalli; P Jeanteur; J M Blanchard
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

5.  Stability of Drosophila RNA polymerase II elongation complexes in vitro.

Authors:  D D Kephart; N F Marshall; D H Price
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.

Authors:  D Eick
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

7.  Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement.

Authors:  G J Wang; M Collinge; F Blasi; R Pardi; J R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.

Authors:  E Muñoz; A M Zubiaga; M Merrow; N P Sauter; B T Huber
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo.

Authors:  L J Strobl; D Eick
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

10.  Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation.

Authors:  D Eick; G W Bornkamm
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.